| Covenant Waiver Extension | 31-Jul-2026 | 07:00 | RNS |
| Permission to Appeal Competition Claim Rejected | 03-Jul-2026 | 07:00 | RNS |
| Covenant Waiver Extension | 30-Jun-2026 | 07:00 | RNS |
| Update on Covenant Waiver, Case & Strategic Review | 01-Jun-2026 | 07:00 | RNS |
| Covenant Waiver Extension | 15-Apr-2026 | 07:30 | RNS |
| Interim results for the HY ended 31 December 2025 | 31-Mar-2026 | 07:00 | RNS |
| Notice of H1 Results, Trading update and IMC | 25-Mar-2026 | 07:00 | RNS |
| Judgment Delivered in Commercial Litigation Claim | 17-Mar-2026 | 07:00 | RNS |
| Judgment Delivered in Commercial Litigation Claim | 17-Mar-2026 | 07:00 | RNS |
| Update on Case Investment and Strategic Review | 11-Mar-2026 | 09:34 | RNS |
| Update on Case Investment and Strategic Review | 11-Mar-2026 | 09:34 | RNS |
| Covenant Waiver Extension | 02-Mar-2026 | 07:00 | RNS |
| Increase in Credit Facility and Waiver Extension | 02-Feb-2026 | 07:00 | RNS |
| Positive development on case | 12-Jan-2026 | 14:07 | RNS |
| Covenant Waiver Extension | 30-Dec-2025 | 07:00 | RNS |
| Currency | UK Pounds |
| Share Price | 1.87p |
| Change Today | 0.14p |
| % Change | 7.80 % |
| 52 Week High | 41.20 |
| 52 Week Low | 1.51 |
| Volume | 335,537 |
| Shares Issued | 114.28m |
| Market Cap | £2.13m |
| RiskGrade | 218 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Latest | Previous | |
|---|---|---|
| Final | Final | |
| Ex-Div | 03-Oct-24 | 28-Sep-23 |
| Paid | 25-Oct-24 | 27-Oct-23 |
| Amount | 1.25p | 2.25p |
| Time | Volume / Share Price |
| 16:06 | 510 @ 1.96p |
| 15:54 | 2,000 @ 1.75p |
| 14:46 | 1,162 @ 1.88p |
| 14:46 | 10,000 @ 1.88p |
| 14:45 | 10,000 @ 1.88p |
| CEO | Patrick Moloney |
| CFO | David Collins |
You are here: research